← FDA Drug Approvals (Drugs@FDA)

JIDEYTRO

NDA · New Drug Application · Sponsor: NUVALENT · Approved 2026-07-22

Drug application

FDA Application #

NDA220185

Application type

New Drug Application

Brand name

JIDEYTRO

Generic name

ZIDESAMTINIB

Active ingredients

ZIDESAMTINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NUVALENT

Manufacturer

Nuvalent, Inc.

First approval

2026-07-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown